Sang Youl Rhee |
11 Articles |
|
Endocrinology-metabolism
Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea
Jin-Hee Lee, Suk Chon, Seon-Ah Cha, Sun-Young Lim, Kook-Rye Kim, Jae-Seung Yun, Sang Youl Rhee, Kun-Ho Yoon, Yu-Bae Ahn, Jeong-Taek Woo, Seung-Hyun Ko; Korean Diabetes Prevention Study Investigators
Korean J Intern Med. 2021;36(2):382-391. Published online March 5, 2020
Background/Aims: We examined the concordance rate among fasting plasma glucose (FPG), 2-hour post-challenge glucose (2hr PG), and hemoglobin A1c (HbA1c) in the diagnosis of diabetes in a population with a high-risk for type 2 diabetes mellitus (T2DM) in Korea.
Methods: Among the participants from th..
|
|
|
Analysis of diabetes quality assessment findings and future directions for the appropriate management of diabetes in Korea
Yu Jin Kim, Suk Chon, Seungjoon Oh, Jeong-taek Woo, Sung Woon Kim, Sang Youl Rhee
Korean J Intern Med. 2019;34(1):125-136. Published online March 15, 2017
Background/Aims: Due to recent increases in the disease burden of diabetes mellitus, the Health Insurance Review and Assessment Service (HIRA) of Korea implemented a quality assessment of the treatment of diabetes to improve patient care. The present study was conducted to identify any changes after..
|
|
|
Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
Seung-Hyun Ko, Kyu Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim; Committee of Clinical Practice Guideline of Korean Diabetes Association
Korean J Intern Med. 2017;32(6):947-958. Published online October 23, 2017
In 2017, the Korean Diabetes Association (KDA) published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the last update in 2015, many results from clinical trials hav..
|
|
|
Monotherapy in patients with type 2 diabetes mellitus
Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim; Committee of Clinical Practice Guideline of Korean Diabetes Association
Korean J Intern Med. 2017;32(6):959-966. Published online October 23, 2017
In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, th..
|
|
|
Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi; on behalf of the Committee of Clinical Practice Guideline of Korean Diabetes Association
Korean J Intern Med. 2017;32(6):967-973. Published online October 23, 2017
The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel ..
|
|
|
Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
Min Kyong Moon, Kyu Yeon Hur, Seung-Hyun Ko, Seok-O Park, Byung-Wan Lee, Jin Hwa Kim, Sang Youl Rhee, Hyun Jin Kim, Kyung Mook Choi, Nan-Hee Kim; on behalf of the Committee of Clinical Practice Guidelines of the Korean Diabetes Association
Korean J Intern Med. 2017;32(6):974-983. Published online October 27, 2017
The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic agents (OHAs), general recommendations were not changed from those of the 20..
|
|
|
Gender disparity in the secular trends for obesity prevalence in Korea: analyses based on the KNHANES 1998-2009
Sang Youl Rhee, Seok Won Park, Dae Jung Kim, Jeongtaek Woo
Korean J Intern Med. 2013;28(1):29-34. Published online December 28, 2012
Background/AimsA similar gender-associated trend in obesity is observed worldwide. Nevertheless, systematic analyses of gender-specific characteristics in the general Korean population are rare. MethodsWe analyzed the prevalence of obesity in Ko..
|
|
|
Familial Clustering of Type 2 Diabetes in Korean Women with Gestational Diabetes Mellitus
Sang Youl Rhee, Joo Young Kim, Jeong-Taek Woo, Young Seol Kim, Sung-Hoon Kim
Korean J Intern Med. 2010;25(3):269-272. Published online August 31, 2010
Background/AimsThis study was conducted to examine the relationship between family history of type 2 diabetes (T2DM) and risk of developing gestational diabetes mellitus (GDM) in Korean women. MethodsWe performed a 100-g oral glucose tolerance t..
|
|
|
Differences in Insulin Sensitivity and Secretory Capacity Based on OGTT in Subjects with Impaired Glucose Regulation
Sang Youl Rhee, Mi Kwang Kwon, Byong-Jo Park, Suk Chon, In-Kyung Jeong, Seungjoon Oh, Kyu Jeung Ahn, Ho Yeon Chung, Sung Woon Kim, Jin-Woo Kim, Young Seol Kim, Jeong-taek Woo
Korean J Intern Med. 2007;22(4):270-274. Published online December 20, 2007
BackgroundThis study examined whether defects in insulin secretion contribute to the development and progression of type 2 diabetes mellitus (T2DM). MethodsPlasma insulin and glucose were measured after a glucose tolerance tes..
|
|
|
Diabcare Asia 2001 - Korea : Country Report on Outcome Data and Analysis
Sang Youl Rhee, Young Seol Kim, Seungjoon Oh, Woong Hwan Choi, Jong Eun Park, Woo Jin Jeong
Korean J Intern Med. 2005;20(1):48-54. Published online March 31, 2005
BackgroundThe Diabcare-Asia study was designed for the purpose of describing diabetes control and management, and late complication status in the diabetic population. MethodsFrom the 1st of July 2001 to the 1st of September..
|
|
